title: Development of an evidence-based clinical guideline for age-appropriate screening, prevention, and management of bone abnormalities in children post-hematopoietic stem cell transplant.
abstract: Musculoskeletal complaints, pain, and weakness are common among children post-hematopoietic stem cell transplant (HSCT). Bone abnormalities include decreased bone mineral density and avascular necrosis, both affecting ambulation and quality of life for survivors. Several risk factors for both disorders among adults have been described along with suggested interventions. However, similar recommendations for screening and management of bone abnormalities among children and adolescents post-HSCT are not clearly defined. A review of the literature using PubMed, CINAHL, National Guideline Clearinghouse, and Cochrane Collection databases identified a paucity of reports specific to the management of bone abnormalities in children and adolescents post-HSCT. Although guidelines for evaluation of bone health in pediatric patients with cancer exist, none specifically address early screening and prevention. The purpose of this article is to provide a review of the literature on current evidence for age appropriate screening, prevention, and management of bone abnormalities in children post-HSCT and to present a clinical guideline for bone abnormalities in children post-HSCT used in a hospital-based outpatient center.
authors: Texas Transplant Physician Group, San Antonio, TX, USA. lisa.mcdonald@mhshealth.com
authors: Lisa
authors: L
authors: McDonald
authors: Julie
authors: J
authors: Luke
authors: Veronica
authors: V
authors: Jude
authors: Kawah
authors: K
authors: Chan
authors: Norma
authors: N
authors: Cuellar
mesh_terms: D000367:Age Factors; D015519:Bone Density; D002648:Child; D019317:Evidence-Based Medicine; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D010020:Osteonecrosis / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy; D017410:Practice Guidelines as Topic